Arthritis Rheumatol
http://www.ncbi.nlm.nih.gov/pubmed/25331004
67(2):327-9
https://connects.catalyst.harvard.edu/Profiles/profile/56064664
Editorial: inflammation, disease-modifying antirheumatic drugs, lipids, and cardiovascular risk in rheumatoid arthritis.
Arthritis Rheumatol
http://www.ncbi.nlm.nih.gov/pubmed/25331004
67(2):327-9
https://connects.catalyst.harvard.edu/Profiles/profile/56064664